Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Obama Foundation CEO Valerie Jarrett Talks Obama Presidential Center Opening
12:33

Senator Elizabeth Warren Talks Iran Deal, Fed's Warsh and SpaceX IPO
17:55

Apollo Chief Economist Torsten Slok Talks Fed Chair Kevin Warsh
06:41